Alternative treatments for osteoarthritis: stem cells, platelet-rich plasma, autologous chondrocyte transplantation, ...: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF). Chairperson: Willem LEMS, Andrew PRICE ‣ Introduction and scope of the problem - Emmanuel MAHEU ‣ Role of surgical regenerative therapies in the management of knee osteoarthritis - Willem LEMS ‣ Role of "alternative" treatments of knee osteoarthritis - Nicholas R. FUGGLE ‣ Conclusion - Andrew PRICE
Is there a role for MHT in the management of post-menopausal osteoporosis? Outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF). Chairperson: Maria Luisa BRANDI, Tim HILLARD ‣ Welcome and scope of the problem - Antonio CANO ‣ Effects of MHT on bone: What, when, how? - Andrea GENAZZANI ‣ Risk/benefit ratio of MHT before and after 60 years - Serge ROZENBERG ‣ Conclusions - Antonio CANO
Radiofrequency Echographic Multi-Spectrometry for the in-Vivo Assessment of Bone Strength: State of the Art: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF). Chairperson: Maria Luisa BRANDI, Adolfo DIEZ PEREZ ‣ Introduction - Hans Peter DIMAI ‣ Current role of bone strength in the assessment of fracture risk - Thierry THOMAS ‣ Radiofrequency echographic multi-spectrometry: Basic principles and clinical validation - Maria Luisa BRANDI
Assessment of cardio-vascular safety of anti-osteoporosis medications. Outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF). Chairperson: Adolfo DIEZ PEREZ, Nicholas R. FUGGLE ‣ Welcome and scope of the problem - Adolfo DIEZ PEREZ ‣ Assessment of cardio-vascular safety of Calcium and Vitamin D - Nicholas HARVEY ‣ Assessment of cardio-vascular safety of menopausal hormonal therapy and SERMs - Santiago PALACIOS ‣ Assessment of cardio-vascular safety of peptides and monoclonal antibodies used as a treatment for osteoporosis - René RIZZOLI ‣ Conclusion - Nicholas R. FUGGLE
Chairperson: Willem LEMS, Andrew PRICE
‣ Introduction and scope of the problem - Emmanuel MAHEU
‣ Role of surgical regenerative therapies in the management of knee osteoarthritis - Willem LEMS
‣ Role of "alternative" treatments of knee osteoarthritis - Nicholas R. FUGGLE
‣ Conclusion - Andrew PRICE
Is there a role for MHT in the management of post-menopausal osteoporosis? Outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairperson: Maria Luisa BRANDI, Tim HILLARD
‣ Welcome and scope of the problem - Antonio CANO
‣ Effects of MHT on bone: What, when, how? - Andrea GENAZZANI
‣ Risk/benefit ratio of MHT before and after 60 years - Serge ROZENBERG
‣ Conclusions - Antonio CANO
Radiofrequency Echographic Multi-Spectrometry for the in-Vivo Assessment of Bone Strength: State of the Art: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairperson: Maria Luisa BRANDI, Adolfo DIEZ PEREZ
‣ Introduction - Hans Peter DIMAI
‣ Current role of bone strength in the assessment of fracture risk - Thierry THOMAS
‣ Radiofrequency echographic multi-spectrometry: Basic principles and clinical validation - Maria Luisa BRANDI
Assessment of cardio-vascular safety of anti-osteoporosis medications. Outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairperson: Adolfo DIEZ PEREZ, Nicholas R. FUGGLE
‣ Welcome and scope of the problem - Adolfo DIEZ PEREZ
‣ Assessment of cardio-vascular safety of Calcium and Vitamin D - Nicholas HARVEY
‣ Assessment of cardio-vascular safety of menopausal hormonal therapy and SERMs - Santiago PALACIOS
‣ Assessment of cardio-vascular safety of peptides and monoclonal antibodies used as a treatment for osteoporosis - René RIZZOLI
‣ Conclusion - Nicholas R. FUGGLE